Search

You searched for "FRCOphth"

241 results found

6.6.2020 – a celebration of international partnerships

5 October 2020 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The date 6.6.2020 was selected as a significant milestone for celebrating the achievements of the VISION LINKS Programme as part of the global ‘VISION 2020: The Right to Sight’ initiative [1]. This virtual full-day seminar included LINK partners in the...

Uncertainties and opportunities in ophthalmology training after the COVID-19 pandemic

6 August 2020 | | EYE - General
Alexander Jones asks what impact the current pandemic will have on ophthalmology trainees. In my work as a Clinical Teaching Fellow, I have to admit that chaos is uncommon. Neither the anxious excitement of rushing to help an unwell patient...

Is patient masking leading to an increase in post-op infection after eyelid surgery?

21 October 2020 | | EYE - Oculoplastic
Due to the COVID-19 pandemic, the use of facemasks or face coverings in the clinical setting has become necessary. It is important to recognise that facemasks can be a source of infection after eye surgery and consider ways to minimise...

SpaMedica announces partnership with Macular Society

26 March 2025 | AMD, macular degeneration, industry, partnership, collaboration, retina
SpaMedica, one of the UK’s leading independent providers of NHS eye care services, is proud to announce a new partnership with the Macular Society, set to launch this month. The collaboration will help to fund ground-breaking research and vital support...

Belfast Eye Conference 2024

22 June 2024 -23 June 2024
by Zina Mobarak, FY1 Doctor, Manchester University Foundation Trust, UK. The Belfast Eye conference was held online over two days, aimed at anyone interested in ophthalmology and focused on delivering informative talks from specialists in various ophthalmic specialties and presenting...

The value of hospital placements in ophthalmology in general practice specialty training

2 February 2024 | | EYE - General
Pratik Bikkannavar provides insights into the potential benefits a placement in ophthalmology provides General Practice Specialty Trainees (GPSTs) and its valuable purpose for the wider ophthalmic community. Ophthalmic complaints are known to account for up to 1 in every 20...

The increasing privatisation of ophthalmology: How has and how will it affect resident doctors?

20 August 2025 | | EYE - Cataract
It’s well known that the rising number of private ophthalmology providers in the UK have continued to increase their market share in providing various services. Referrals from NHS trusts have continued to increase with nearly 60% of cataract operations being...

Should points for simulated surgery be removed from the ophthalmology ST1 evidence folder?

2 April 2025 | | EYE - General
The benefits of the Eyesi surgical simulator by Haag-Streit UK for early career ophthalmology speciality trainees are well-established, allowing for the practice of cataract and vitreoretinal surgery in a controlled, risk-free environment. Whilst the Eyesi is an invaluable resource for...

Haag-Streit UK looks forward to exhibiting at the RCOphth Annual Congress 2023

28 March 2023 | Awards, Conferences & Anniversaries
Haag-Streit UK is pleased to announce it will be exhibiting at Royal College of Ophthalmologists (RCOphth) Annual Congress on 22-25 May 2023 at the ICC in Birmingham.

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

22 May 2023 | Research & Development, Awards, Conferences & Anniversaries
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Vabysmo receives NICE approval

27 September 2024 | Awards, Conferences & Anniversaries, Company Profiles, Research & Development
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...

Building research capacity through the VISION 2020 LINKS Programme

1 August 2017 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The aim is to build capacity for research in the region covered by the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA). The project will build research capacity in three ophthalmology training institutions by ‘training the trainers’ and...